← All diseases Rare and hereditary disorders

Epidermolysis bullosa

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchMost rigorous evidence only (52)Treatment guideline (7)Meta-analysis (4)Systematic review (18)Phase 3 Study (15)Randomized trial (8)Clinical trial (147)Review article (153)Early study (phase 1 or 2) (20)Single patient description (248)Laboratory or animal research (18)Commentary or editorial (88)Retracted publication (1) Studies currently recruiting participants only (33)

Filter

Publications and studies (1209)

• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Intravenous Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB) (2022-11-03) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Optimizing IV Gentamicin in JEB (2022-11-03) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Allogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis Bullosa (2022-10-07) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Evaluation of the Safety and Efficacy Study of RGN-137 Topical Gel for Junctional and Dystrophic Epidermolysis Bullosa (2022-08-22) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Growth Hormone in EB (2022-05-25) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Topical Gentamicin Nonsense Suppression Therapy of EB (2022-05-03) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Dose-ranging Study of Dentoxol® Mouthrinse for Managing Oral Symptoms in People With Epidermolysis Bullosa. (2022-04-14) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study (2022-03-09) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Clinical Trial to Assess Safety and Efficacy of Autologous Cultured Epidermal Grafts Containing Epidermal Stem Cells Genetically Modified in Patients With JEB (HOLOGENE17) (2022-03-07) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Clinical Trial to Assess Safety and Efficacy of Autologous Cultured Epidermal Grafts Containing Epidermal Stem Cells Genetically Modified in Patients With RDEB. (2022-02-16) ♡
• Identifying Epidermolysis Bullosa Patient Needs and Perceived Treatment Benefits: An Explorative Study Using the Patient Benefit Index. (2021/12/13) ♡
• Availability of mRNA Obtained from Peripheral Blood Mononuclear Cells for Testing Mutation Consequences in Dystrophic Epidermolysis Bullosa. (2021/12/13) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Transgenic Epidermal Cultures for Junctional Epidermolysis Bullosa - 5-Year Outcomes. (2021/12/09) ♡
• Preimplantation Genetic Diagnosis for DEB by Detecting a Novel Family-Specific COL7A1 Mutation in Vietnam. (2021/12/09) ♡
• Molecular origin of the effects of mutation on the structure and mechanical properties of human epithelial keratin K5/K14. (2021/12/01) ♡
• Practical management of epidermolysis bullosa: consensus clinical position statement from the European Reference Network for Rare Skin Diseases. (2021/12/01) ♡
• Novel pathogenic variants in an Indian cohort with epidermolysis bullosa: Expanding the genotypic spectrum. (2021/12/01) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Bullous Dermatoses and Depression: A Systematic Review. (2021/12/01) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Generation and genetic repair of two human induced pluripotent cell lines from patients with Epidermolysis Bullosa simplex and dilated cardiomyopathy associated with a heterozygous mutation in the translation initiation codon of KLHL24. (2021/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A novel ITGA3 homozygous splice mutation in an ILNEB syndrome child with slow progression. (2021/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Application of topical gentamicin-a new era in the treatment of genodermatosis. (2021/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The pathogeneses of pemphigus and pemphigoid diseases. (2021/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Current topics in Epidermolysis bullosa: Pathophysiology and therapeutic challenges. (2021/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A Case Report of an Infant with Autosomal Recessive Dystrophic Epidermolysis Bullosa: COL7A1 Gene Mutations at C2005T and G7922A. (2021/12/01) ♡
• Efficacy of gentamicin 0.3% solution of oral erosions healing in patients with severe generalized recessive dystrophic epidermolysis bullosa and its impact on the expression of type VII collagen. (2021/12/01) ♡
• Bullous diseases caused by KRT1 gene mutations: from epidermolytic hyperkeratosis to a novel variant of epidermolysis bullosa simplex. (2021/12/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. CRISPR-Cas9‒Based Genomic Engineering in Keratinocytes: From Technology to Application. (2021/12/01) ♡
• Role of regional anaesthesia in a patient with epidermolysis bullosa dystrophica for emergency surgery. (2021/12/01) ♡
• Damaged Keratin Filament Network Caused by KRT5 Mutations in Localized Recessive Epidermolysis Bullosa Simplex. (2021/11/29) ♡
• Development of Minicircle Vectors Encoding COL7A1 Gene with Human Promoters for Non-Viral Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa. (2021/11/26) ♡
• Clinical trial of ABCB5+ mesenchymal stem cells for recessive dystrophic epidermolysis bullosa. (2021/11/22) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Keratins as an Inflammation Trigger Point in Epidermolysis Bullosa Simplex. (2021/11/18) ♡
• Frequency of genotypic markers for genetic disorders, colour, polledness, and major genes in Blanco Orejinegro cattle. (2021/11/15) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Therapeutic Prospects of Exon Skipping for Epidermolysis Bullosa. (2021/11/12) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Impact of low-dose calcipotriol ointment on wound healing, pruritus and pain in patients with dystrophic epidermolysis bullosa: A randomized, double-blind, placebo-controlled trial. (2021/11/08) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case Report: De novo KLHL24 Gene Pathogenic Variants in Chinese Twin Boys With Epidermolysis Bullosa Simplex. (2021/11/05) ♡
• Economic Burden of Epidermolysis Bullosa Disease in Iran. (2021/11/03) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Classification of 2 distinct wound types in recessive dystrophic epidermolysis bullosa: A retrospective and cohort natural history study. (2021/11/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Oral potentially malignant disorders: A consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer. (2021/11/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Amelioration of dystrophic epidermolysis bullosa pruriginosa symptoms with dupilumab: A case report. (2021/11/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A multicentre prospective analysis of the incidence of pemphigoid diseases in Turkey. (2021/11/01) ♡
• Characterization of mutant type VII collagens underlying the inversa subtype of recessive dystrophic epidermolysis bullosa. (2021/11/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Congenital myopathy and epidermolysis bullosa due to PLEC variant. (2021/11/01) ♡
• Congenital Pyloric Atresia: Experience with a Series of 11 Cases and Collective Review. (2021/11/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Very-Early-Onset Inflammatory Bowel Disease in a Patient With Junctional Epidermolysis Bullosa With a Homozygous Mutation in the α6 Integrin Gene (ITGA6). (2021/10/20) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Future Perspectives of Oral Delivery of Next Generation Therapies for Treatment of Skin Diseases. (2021/10/18) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Editorial: Gene, Cell and Protein Replacement Therapy for Genetic Muscle, Bone and Skin Disorders. (2021/10/18) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Plectin in Skin Fragility Disorders. (2021/10/14) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Preventive but Not Therapeutic Topical Application of Local Anesthetics Can Inhibit Experimental Epidermolysis Bullosa Acquisita in Mice. (2021/10/12) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Deconstructing progressive inflammatory fibrosis in recessive dystrophic epidermolysis bullosa. (2021/10/07) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.